Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cerevel Therapeutics Hldg Inc (NQ: CERE )

21.05 +0.49 (+2.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 673,419
Open 20.71
Bid (Size) 21.27 (1)
Ask (Size) 22.40 (1)
Prev. Close 20.56
Today's Range 20.55 - 21.19
52wk Range 19.96 - 35.98
Shares Outstanding 8,830,700
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to... 
Via Benzinga
$2M Bet On Biohaven? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Monday, there were a few notable insider trades. 
Via Benzinga

Performance

YTD
-31.99%
-31.99%
1 Month
-8.48%
-8.48%
3 Month
-35.37%
-35.37%
6 Month
-15.36%
-15.36%
1 Year
-24.06%
-24.06%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
Via Benzinga
Why Is Cerevel Therapeutics Stock Trading Lower Today?
Via Benzinga
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Shares of Cerevel Therapeutics Are Dropping Wednesday
Via The Motley Fool
Analyst Expectations for Cerevel Therapeutics Hldg's Future
Via Benzinga
Analyst Expectations for Cerevel Therapeutics Hldg's Future
Via Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
Via Benzinga
Top 5 Health Care Stocks That Should Keep You Up At Night
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
Via Benzinga
Cerevel Therapeutics Hldg: Q1 Earnings Insights
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Where Cerevel Therapeutics Hldg Stands With Analysts
Via Benzinga
Analyst Expectations for Cerevel Therapeutics Hldg's Future
Via Benzinga
Data Shows Cerevel's Emraclidine Does Not Induce High Blood Pressure In Schizophrenia Patients
Via Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 10, 2023
Via Benzinga
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
Via Benzinga
Analyst Views Karuna Therapeutics' New Licensing Deal 'As Intriguing'
Via Benzinga
Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday
Via Benzinga
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.